Sita Bio provides a mechanism‑first platform that integrates clinical data with deep endometrial molecular profiling to define distinct biological states underlying early pregnancy loss and implantation failure. The platform delivers high‑resolution maps of uterine microvasculature and cellular composition, enabling fertility clinics to stratify patients and receive data‑driven protocol recommendations, while also supporting research into new therapeutic candidates.
Funding
Funding not disclosed
Founders
Product
Problem
Early pregnancy loss and implantation failure affect many patients, yet clinicians lack detailed mechanistic insight into the underlying biological states, making it difficult to tailor treatments and improve outcomes.
Solution
Sita Bio offers a mechanism-first platform that combines clinical data with deep endometrial profiling to define distinct biological states associated with early pregnancy failure. The platform generates high‑resolution maps of uterine microvasculature and cellular composition, enabling clinicians to stratify patients based on mechanistic signatures rather than generic outcomes. By linking these signatures to actionable protocols and adjunct therapies, Sita Bio helps clinics select more appropriate treatment pathways for each patient. The system also supports discovery of new therapeutic candidates by providing a controlled, data‑rich environment for testing interventions aimed at implantation failure and recurrent miscarriage. Ultimately, the platform aims to increase the likelihood that the first embryo transfer succeeds.
Target Audience
Primary customers are fertility clinics and reproductive medicine specialists seeking mechanistic insight to guide treatment decisions, as well as research partners developing therapies for early pregnancy loss.
Features
- Integrated clinical and molecular profiling pipeline that characterizes endometrial tissue at cellular and vascular levels
- Perfusable uterine microvasculature models that replicate early‑pregnancy physiology for mechanistic testing
- Data‑driven patient stratification tools that map clinical observations to specific biological states
- Protocol recommendation engine that suggests tailored embryo transfer and adjunct treatment options based on identified mechanisms
- Research interface for discovering and prioritizing therapeutic candidates targeting implantation failure and recurrent miscarriage